Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Kalypsys and CV Therapeutics collaborate on cardiovascular disease

Nov. 24, 2003

Positive results announced for aliskiren in hypertension

Nov. 21, 2003

GSK scientists identify novel Lp-PLA2 inhibitors for use in atherosclerosis therapy

Nov. 21, 2003

Adenoviral gene therapy improves myocardial perfusion in stable angina

Nov. 21, 2003

Atherosclerosis regression with an apo A-I mimetic in acute coronary syndrome patients

Nov. 19, 2003

deCODE acquires Bayer compound for heart attack prevention

Nov. 19, 2003

New thyroid receptor antagonists and their use described in Karo Bio patent

Nov. 18, 2003

Caspase-3 inhibition preserves myocardial geometry and long-term function postinfarction in mice

Nov. 18, 2003

VX-702, a p38 MAPK inhibitor, reduces myocardial ischemia-reperfusion damage in rats

Nov. 14, 2003

Antiproliferative and differentiation-inducing effects of ratjadone on coronary smooth muscle cells

Nov. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...